Source: International Congress 2018 – Advanced profiling of immune cells in chronic lung diseases
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
J. Garner (London, United Kingdom), S. Soni (London, United Kingdom), K. O'Dea (London, United Kingdom), K. Srikanthan (London, United Kingdom), E. Tenda (London, United Kingdom), A. Aboelhassan (London, United Kingdom), S. Singh (London, United Kingdom), S. Kemp (London, United Kingdom), M. Wilson (London, United Kingdom), O. Usmani (London, United Kingdom), P. Shah (London, United Kingdom), M. Takata (London, United Kingdom). Late Breaking Abstract - Intra-alveolar neutrophil-derived microvesicles: a biomarker of COPD severity. 4921

Member's Comments

No comment yet.

Related content which might interest you: Late Breaking Abstract - Blood and bronchoalveolar neutrophil signatures associate with COPD severity Source: Virtual Congress 2021 – Patient-reported outcome measures (PROMs): easy tools in the management of chronic respiratory diseases Year: 2021 Late Breaking Abstract - Treatment with ATYR1923 reduces biomarkers in COVID-19 pneumonia Source: Virtual Congress 2021 – Diagnosis and management of COVID-19 Year: 2021 Late Breaking Abstract - Detection of clinical instability by eNose in COPD patients Source: International Congress 2018 – How far are we in terms of predicting mortality and exacerbations in COPD? Year: 2018 Late Breaking Abstract - Plasma cells and endothelitis in COVID-19 lung pathology Source: Virtual Congress 2020 – Covering COVID - the best abstracts Year: 2020 Late Breaking Abstract - Systemic ferritin is an early disease biomarker for silicosis patients Source: Virtual Congress 2021 – Prognostic markers of disease progression in non-idiopathic pulmonary fibrosis interstitial lung diseases Year: 2021 Late Breaking Abstract - Myeloid-derived microvesicles as acute mediators of sepsis-induced lung vascular inflammation Source: Virtual Congress 2020 – Cellular involvement in lung injury Year: 2020 Late Breaking Abstract - The inflammasome cluster is linked with airway NETosis in COPD Source: Virtual Congress 2021 – Cellular and molecular involvement in lung injury and repair Year: 2021 Late Breaking Abstract - Mepolizumab reduces exacerbations in eosinophilic COPD Source: International Congress 2017 – Late-breaking studies in asthma and COPD Year: 2017 Late Breaking Abstract - Association between blood eosinophils and exacerbation risk in COPD primary care Source: International Congress 2017 – COPD: from screening to risk factors of lung cancer Year: 2017 Endothelial microparticles in sputum of COPD patients: A potential biomarker of disease Source: International Congress 2015 – Systemic and airway biomarkers Year: 2015 Late Breaking Abstract: Expression of S100A4 in COPD Source: Annual Congress 2010 - Novel mechanisms in COPD Year: 2010 Late Breaking Abstract - Clinical characteristics and lung function trends of severe eosinophilic asthma patients unresponsive to Mepolizumab Source: International Congress 2019 – Blood eosinophils and more in airway diseases Year: 2019 Late Breaking Abstract - Biological determinants of sputum rheology in chronic airway diseases Source: Virtual Congress 2020 – Monitoring of inflammation in remodelling Year: 2020 Late Breaking Abstract - Plasma endocan is over-expressed in AECOPD patients: association with lung function decline and apoptosis Source: International Congress 2018 – Biomarkers of COPD Year: 2018 Late Breaking Abstract - Early response to benralizumab in Canadians with severe eosinophilic asthma Source: Virtual Congress 2021 – Asthma clinical trials and real-life studies Year: 2021 Late Breaking Abstract - Identification of patients with COPD who benefit from benralizumab Source: International Congress 2019 – ALERT: Abstracts Leading to Evolution in Respiratory Medicine Trials: COPD and cough Year: 2019 Late Breaking Abstract - Prognostic value of serum biomarkers in patients with idiopathic pulmonary fibrosis and correlation with disease progression. Source: Virtual Congress 2021 – Exercise tolerance, supportive care and more in non-pulmonary fibrosis interstitial lung diseases Year: 2021 Human neutrophil gelatinase-associated lipocalin: A new biomarker in asthma-COPD overlap syndrome Source: International Congress 2016 – Notable abstracts on clinical problems related to asthma Year: 2016 Late Breaking Abstract - Matrix metalloproteinases in serum and sputum reflect distinct processes of relevance to asthma Source: International Congress 2019 – Precision meets immunology in treatment of airway diseases Year: 2019 Late Breaking Abstract - Benralizumab treatment strongly reduces blood basophils in patients with severe eosinophilic asthma Source: International Congress 2019 – Understanding, monitoring and targeting severe asthma Year: 2019